SAN DIEGO--(BUSINESS WIRE)--Apr 10, 2025--
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States. With an overall MARD of 8.0%, 3 Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia and increase time in range. 4-8
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250410304660/en/
“The approval of Dexcom G7 15 Day marks another major innovation for Dexcom,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “By listening to the needs of our users, we’re proud to offer the longest lasting wearable and most accurate CGM, giving people the knowledge to better control their diabetes with our best-in-class technology. This milestone sets a new standard in CGM and is a testament to our continued leadership in glucose biosensing. We look forward to bringing it to market in the second half of this year, but in the meantime, we encourage our users to upgrade to our current G7 system to gain the benefits of the most connected CGM brand in the world.”
New with Dexcom G7 15 Day
Dexcom G7 features included with Dexcom G7 15 Day
“Dexcom G7 15 Day makes managing diabetes even easier with its extended wear and greater accuracy,” said Satish Garg, MD, from Barbara David Center for Diabetes at the University of Colorado School of Medicine. “Data recently released during the 18th international Advanced Technologies and Treatments for Diabetes conference in Amsterdam supports that G7 15 Day is the most accurate CGM for adults.”
Dexcom is working closely with its insulin pump partners to ensure that Dexcom G7 15 Day will be compatible with automated insulin delivery systems upon launch. Dexcom G7 15 Day is expected to launch in the US in the second half of 2025.
VisitDexcom.com/startto get started with Dexcom G7 today. To learn more about Dexcom G7 15 Day and for additional information about when it will be available in the US, visitDexcom.com/15day.
About Dexcom
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.
Category: IR
* A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per package labeling, approximately 26% of sensors may not last for the full 15 days. † Excludes implantable CGM systems. ‡ Compared to a prior generation Dexcom CGM System. § The Dexcom G7 Sensor is water-resistant and may be submerged under eight feet of water for up to 24 hours without failure when properly installed. || Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 33 feet of the Dexcom G7. ¶ Smart device sold separately. To view a list of compatible devices, visit dexcom.com/compatibility. # Automated activity and medication logging available in Dexcom G7 app only. ** Healthcare providers can register for Dexcom Clarity at clarity.dexcom.com/professional/registration. †† An internet connection is required for patients to send their glucose data to Dexcom Clarity via a compatible smart device: dexcom.com/compatibility. Healthcare providers will only be able to view a patient’s glucose data if the patient elects to share it with them through Dexcom Clarity. ‡‡ Separate Dexcom Follow app and internet connection required. Users should always confirm readings on the Dexcom G7 app or receiver before making treatment decisions.
1 Dexcom, Data on File, 2025. 2 Dexcom, Data on File, 2023. 3 Garg SK, et al. Diabetes Technol Ther. 2025. doi: 10.1089/dia.2025.0139. Epub ahead of print. 4 Beck RW, et al. JAMA. 2017;317(4):371-378. 5 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 6 Martens T, et al. JAMA. 2021;325(22):2262-2272. 7 Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 8 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7. 9 Polonsky WH, et al. Diabetes Technol Ther. 2021;23(3):195-202.
Now the longest lasting and most accurate CGM system, Dexcom G7 15 Day gives users the knowledge to better control diabetes.
Dexcom G7 15 Day is now cleared in the US for people age 18 years and above with diabetes.
NEW YORK (AP) — Stocks of credit card companies are dropping Monday after President Donald Trump threatened moves that could eat into their profits. The rest of Wall Street, meanwhile, was showing only modest signals of concern after tensions ramped to a much higher degree between the White House and the Federal Reserve.
The S&P 500 edged down by 0.1% from its all-time high as U.S. stocks drifted through mixed trading, while prices for gold and other investments that tend to do well when investors are nervous rose. The value of the U.S. dollar also dipped against other currencies amid some concern that the Fed may have less independence in setting interest rates to keep inflation under control.
The Dow Jones Industrial Average was down 151 points, or 0.3%, as of 10:45 a.m. Eastern time, and the Nasdaq composite was down 0.1%.
Some of the stock market's sharpest drops hit credit card companies, as Synchrony Financial, Capital One Financial and American Express all fell between 5% and 9%. They sank after Trump said he wanted to put a 10% cap on credit card interest rates for a year. Such a move could eat into profits for credit card companies.
But it was a separate move by Trump that was grabbing more attention on Wall Street. Over the weekend, the Federal Reserve’s chair said the U.S. Department of Justice subpoenaed the Fed and threatened a criminal indictment over his testimony about renovations at its headquarters.
With an unusual video statement released on Sunday, Fed Chair Jerome Powell said his testimony and the renovations are “pretexts” for the threat of criminal charges, which is really “a consequence of the Federal Reserve setting interest rates based on our best assessment of what will serve the public, rather than following the preferences of the President.”
The Fed has been locked in a feud with Trump, who has loudly called for lower interest rates that would make borrowing cheaper for U.S. households and companies and could give the economy a kickstart. The Fed did lower its main interest rate three times last year and indicated more cuts may be arriving this year, but it’s moved deliberately enough that Trump has nicknamed Powell “Too Late.”
In a brief interview with NBC News Sunday, Trump insisted he didn’t know about the investigation into Powell. When asked if the investigation is intended to pressure Powell on rates, Trump said, “No. I wouldn’t even think of doing it that way.”
The Fed has traditionally operated separately from the rest of Washington, making its decisions without having to bend to political whims. Such independence, the thinking goes, gives it the freedom to keep interest rates high when necessary to drive down high inflation, even if it slows the economy and frustrate politicians looking to please voters.
In the bond market, the yield on the 10-year Treasury briefly reached 4.21%, up from 4.18% late Friday, amid concerns that a less independent Fed could mean higher inflation over the longer term. But it later eased back to 4.18%.
The worries also hit the value of the U.S. dollar, which slipped 0.4% against the euro and 0.4% against the Swiss franc.
A couple reasons could be behind markets shaking off the concerns about the Fed, including how it may ultimately play out for the best, according to Giuseppe Sette, president of Reflexivity, an AI investment analytics platform. Trump has already criticized the Fed sharply, and he's trying at the moment to fire Fed Gov. Lisa Cook, but the Fed's rate-setting committee still seems to be acting independently.
Plus, this latest move could encourage Powell to stay on at the Fed as a governor until his term expires in 2028, even though his term as chair will end in May, said Brian Jacobsen, chief economist at Annex Wealth Management.
“With the political pressure on the Fed, he may choose to stay on as a governor out of spite,” he said. "It would deprive President Trump of the ability to stack the board with another appointee."
On Wall Street, Abercrombie & Fitch dropped 17.4% after the retailer gave a forecasted range for profit in the final quarter of 2025 whose midpoint fell short of analysts' expectations. Its forecast for growth in revenue also fell shy of Wall Street's.
On the winning side of the market was Walmart, which rose 2.5% after learning that its stock will join the widely followed Nasdaq 100 index. Google also said Sunday that it's expanding the shopping features in its AI chatbot by teaming up with Walmart and several other big retailers.
The price of gold rose 3% to $4,635.40 per ounce and was heading toward another record.
In stock markets abroad, indexes rose across much of Europe and Asia. Stocks jumped 1.4% in Hong Kong and 1.1% in Shanghai for two of the world’s bigger gains following reports that Chinese leaders were preparing more help for the economy.
AP Business Writers Matt Ott and Elaine Kurtenbach contributed.
Traders work on the floor at the New York Stock Exchange in New York, Friday, Jan. 9, 2026. (AP Photo/Seth Wenig)
James Lamb works on the floor at the New York Stock Exchange in New York, Friday, Jan. 9, 2026. (AP Photo/Seth Wenig)
Specialist Anthony Matesic works on the floor of the New York Stock Exchange, Thursday, Jan. 8, 2026. (AP Photo/Richard Drew)
Daniel Kryger works on the floor at the New York Stock Exchange in New York, Friday, Jan. 9, 2026. (AP Photo/Seth Wenig)
Dealers watch computer monitors near the screens showing the foreign exchange rate between U.S. dollar and South Korean won at a dealing room of Hana Bank in Seoul, South Korea, Monday, Jan. 12, 2026. (AP Photo/Lee Jin-man)
A dealer walks near the screens showing the foreign exchange rate between U.S. dollar and South Korean won and the Korean Securities Dealers Automated Quotations (KOSDAQ) at a dealing room of Hana Bank in Seoul, South Korea, Monday, Jan. 12, 2026. (AP Photo/Lee Jin-man)
Dealers talk near the screens showing the Korea Composite Stock Price Index (KOSPI), left, and the foreign exchange rate between U.S. dollar and South Korean won at a dealing room of Hana Bank in Seoul, South Korea, Monday, Jan. 12, 2026. (AP Photo/Lee Jin-man)
A dealer walks near the screens showing the foreign exchange rates at a dealing room of Hana Bank in Seoul, South Korea, Monday, Jan. 12, 2026. (AP Photo/Lee Jin-man)
